Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ARTV
ARTV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ARTV News
GT Biopharma: Three Drugs Enter Human Trials
1d ago
PRnewswire
GT Biopharma Advances Three Drug Candidates in Clinical Trials
1d ago
Newsfilter
Artiva Reports Positive Clinical Data for AlloNK Therapy
May 08 2026
stocktwits
Artiva Biotherapeutics Releases Initial Data from Mid-Stage Trial
May 08 2026
seekingalpha
Artiva Biotherapeutics Q1 Financial Report Analysis
May 08 2026
seekingalpha
Artiva Biotherapeutics Completes Stock Offering
May 08 2026
NASDAQ.COM
Artiva Biotherapeutics Reports Initial AB-101 Clinical Data
May 08 2026
Newsfilter
Artiva Biotherapeutics Reports Positive Initial Clinical Data for AlloNK
May 08 2026
Newsfilter
Artiva Biotherapeutics Reports 2025 Financial Results and Pipeline Progress
Mar 11 2026
NASDAQ.COM
Artiva Biotherapeutics Reports FY GAAP EPS of -$3.43
Mar 10 2026
seekingalpha
Artiva Biotherapeutics Appoints New CFO
Feb 24 2026
NASDAQ.COM
NanoSyrinx Appoints New CEO to Advance Nanosyringe Technology
Jan 08 2026
Newsfilter
Crude Oil Declines by More Than 1%; US Homebuilder Confidence Rises Slightly in December
Dec 15 2025
Benzinga
US Stocks Show Varied Performance as NY Manufacturing Activity Declines in December
Dec 15 2025
Benzinga
After-Hours Stock Surge: Exicure Leads with 72% Increase, Followed by Wave Life and Assembly Biosciences
Dec 09 2025
NASDAQ.COM
Artiva Biotherapeutics (ARTV) Soars 113.9% Following FDA Fast Track Designation for AlloNK in Refractory RA – Is the Bullish Outlook Still Valid?
Oct 19 2025
Yahoo Finance
Show More News
